Park Ha Biological Technology Co., Ltd. is trading 6% down today at $1.41 after closing a $2.0 million registered direct stock offering priced at $1.50 per share and pre-funded warrant units.
- This transaction marks the company’s second equity raise this year, intensifying investor concerns regarding shareholder dilution.
- The micro-cap stock continues to exhibit high volatility following a period of extreme price spikes and pullbacks driven by momentum trading.